Curatis Holding AG | WebDisclosure

PRESS RELEASE

published on 09/18/2025 at 07:00, 9 months 25 days ago

FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
Curatis Holding AG receives positive outcome confirmation from FDA meeting regarding corticorelin's Phase 3 development plan for patients with PTBE secondary to solid tumor brain metastases

Phase 3 Curatis Holding AG FDA Meeting Corticorelin PTBE
BRIEF

published on 09/15/2025 at 07:05, 9 months 28 days ago

Curatis annonce une croissance de son chiffre d'affaires et fait progresser le développement du C-PTBE-01

Partenariat Croissance Des Revenus Curatis Holding AG Réunion De La FDA Développement Du C-PTBE-01
BRIEF

published on 09/15/2025 at 07:05, 9 months 28 days ago

Curatis Reports Revenue Growth and Advances C-PTBE-01 Development

Revenue Growth Partnership Curatis Holding AG FDA Meeting C-PTBE-01 Development
PRESS RELEASE

published on 09/15/2025 at 07:00, 9 months 28 days ago

Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01
Curatis Holding AG reports double-digit revenue growth in H1 2025, signing a significant partnership with Phoenix Labs for C-PTBE-01. Financials show a loss due to increased development expenses for corticorelin

Revenue Growth Partnership Financials Curatis Holding AG C-PTBE-01
BRIEF

published on 09/05/2025 at 07:05, 10 months 8 days ago

Curatis va augmenter ses revenus grâce à un partenariat avec Phoenix Labs

Suisse Accord De Distribution Croissance Des Revenus Curatis Laboratoires Phoenix
BRIEF

published on 09/05/2025 at 07:05, 10 months 8 days ago

Curatis to Boost Revenue with Phoenix Labs Partnership

Revenue Growth Distribution Agreement Switzerland Curatis Phoenix Labs
PRESS RELEASE

published on 09/05/2025 at 07:00, 10 months 8 days ago

Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG announces new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland, expecting up to CHF 5 million additional annual revenues from October 2025

Revenue Growth Switzerland Curatis Holding AG Phoenix Labs Distribution Contract
BRIEF

published on 07/31/2025 at 06:05, 11 months 13 days ago

FDA Schedules Type B Meeting for Curatis' Phase 3 Corticorelin Trial

Phase 3 Trial Curatis Holding AG FDA Meeting Corticorelin PTBE Treatment
BRIEF

published on 07/31/2025 at 06:05, 11 months 13 days ago

La FDA organise une réunion de type B pour l'essai de phase 3 de Curatis sur la corticoréline

Essai De Phase 3 Curatis Holding AG Réunion De La FDA Corticoréline Traitement PTBE
PRESS RELEASE

published on 07/31/2025 at 06:00, 11 months 13 days ago

FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
FDA confirms Type B meeting with Curatis Holding AG to review Phase 3 plan for investigational biologic corticorelin, targeting Peritumoral Brain Edema. Development aims to reduce steroid use in patients

FDA Phase 3 Study Curatis Holding AG Corticorelin Type B Meeting

Published on 07/14/2026 at 01:45, 2 hours 46 minutes ago

Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 4 hours 30 minutes ago

Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 5 hours 21 minutes ago

Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 6 hours 56 minutes ago

ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 8 hours 31 minutes ago

IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE

Published on 07/13/2026 at 22:30, 6 hours ago

Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 7 hours 10 minutes ago

Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 7 hours 13 minutes ago

EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 20:48, 7 hours 42 minutes ago

EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026
Published on 07/13/2026 at 20:23, 8 hours 8 minutes ago

EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations

View all EQS

Published on 07/13/2026 at 18:00, 10 hours 31 minutes ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 10 hours 31 minutes ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 10 hours 31 minutes ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 10 hours 31 minutes ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 10 hours 46 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News